Modeling of degradation and drug release from a biodegradable stent coating.

Biodegradable polymeric coatings on cardiovascular stents can be used for local delivery of therapeutic agents to diseased coronary arteries after stenting procedures. This can minimize the occurrence of clinically adverse events such as restenosis after stent implantation. A validated mathematical model can be a very important tool in the design and development of such coatings for drug delivery. The model should incorporate the important physicochemical processes responsible for the polymer degradation and drug release. Such a model can be used to study the effect of different coating parameters and configurations on the degradation and the release of the drug from the coating. In this paper, a simultaneous transport-reaction model predicting the degradation and release of the drug Everolimus from a polylactic acid (PLA) based stent coating is presented. The model has been validated using in vitro testing data and was further used to evaluate the influence of various parameters such as partitioning coefficient of water, autocatalytic effect of the lactic acid and structural change of the matrix, on the PLA degradation and drug release. The model can be used as a tool for predicting drug delivery from other coating configurations designed using the same polymer-drug combination. In addition, this modeling methodology has broader applications and can be used to develop mathematical models for predicting the degradation and drug release kinetics for other polymeric drug delivery systems.

[1]  Dean G. Duffy.  Solutions of Partial Differential Equations , 1986 .

[2]  G. Boering,et al.  Resorbable materials of poly(L-lactide). VII. In vivo and in vitro degradation. , 1987, Biomaterials.

[3]  P Nieuwenhuis,et al.  Enzymatic activity toward poly(L-lactic acid) implants. , 1990, Journal of biomedical materials research.

[4]  J. Tanguay,et al.  Current status of biodegradable stents. , 1994, Cardiology clinics.

[5]  S. Silber,et al.  Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions , 2003, Circulation.

[6]  S. Hossainy,et al.  Therapy considerations in drug-eluting stents. , 2005, Critical reviews in therapeutic drug carrier systems.

[7]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.

[8]  J. Siepmann,et al.  Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.

[9]  Ping I. Lee.  Diffusional release of a solute from a polymeric matrix — approximate analytical solutions , 1980 .

[10]  Patrick W Serruys,et al.  New frontiers in cardiology: drug-eluting stents: Part I. , 2003, Circulation.

[11]  S. W. Kim,et al.  Drug release from hydrogel devices with ratecontrolling barriers , 1980 .

[12]  A. Göpferich,et al.  Erosion of composite polymer matrices. , 1997, Biomaterials.

[13]  R. W. Baker,et al.  THEORY AND PRACTICE OF CONTROLLED DRUG DELIVERY FROM BIOERODIBLE POLYMERS , 1980 .

[14]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[15]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[16]  A. Joshi,et al.  Dynamics of controlled release from bioerodible matrices , 1991 .

[17]  J. Benoit,et al.  Biodegradable cisplatiim microspheres prepared by the solvent evaporation method: Morphology and release characteristics , 1988 .

[18]  R. Linhardt,et al.  Degradation of poly(ester) microspheres. , 1990, Biomaterials.

[19]  W. O’Neill,et al.  Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy , 2004, Circulation.

[20]  A. Laroia,et al.  Drug-Eluting Stents: A Review of the Current Literature , 2004, Cardiology in review.